Patients with sarcoma often require a combination of surgery, chemotherapy, and radiation therapy. We recognize that a team approach is the best way to manage these complicated cases. Our group is dedicated to clinical research to develop cutting-edge treatment strategies for both soft tissue and bone malignancies.
The Center for Sarcoma and Bone Oncology has dedicated specialty expertise in the pathologic and radiologic assessment of sarcoma, the application of novel soft-tissue and bone reconstructive techniques, and access to promising new therapies.
Patients with sarcoma often require a combination of surgery, chemotherapy, and radiation therapy. We recognize that a team approach to treatment is the best way to manage these complicated cases.
Our specialists focus exclusively on sarcoma and work closely together to offer these services in a coordinated manner.
Our group is also dedicated to clinical research to help identify and develop cutting-edge treatment strategies for both soft tissue sarcomas and bone malignancies such as osteosarcoma, resulting in reduced recurrence rates and improved outcomes for patients.
Our specialists see patients with all types of sarcoma and a variety of mesenchymal tumors, including:
When you come to Dana-Farber Cancer Institute for sarcoma treatment, you will meet with members of our team who have specialized expertise in caring for patients with sarcoma.
This means pathologists, medical oncologists, radiologists, surgeons and other health care professionals with expertise in sarcoma may be involved in important decisions about your care.Learn about our multidisciplinary approach to sarcoma treatment
When our pathologists confirm a sarcoma diagnosis, our clinicians meet to discuss next steps. The treatment plan is tailored, as much as possible, to each individual patient and their disease profile, taking into account such details as the patient's age, prior medical conditions, lifestyle and personal preferences.Learn about the role of pathology in sarcoma diagnosis and treatment
If the sarcoma is localized — if it has not spread to other parts of the body — the goal is to cure the patient. This could involve surgery and radiation, with chemotherapy also used in certain types of sarcoma. It is important to involve an experienced sarcoma surgeon in treatment decisions.Learn about the role of the surgical oncologist in sarcoma treatment
If the sarcoma is advanced, or metastatic, the goal is to give the patient as high a quality of life as possible for as long as possible, and cure in some cases. This may involve some surgery, chemotherapy or radiation therapy, and observation. We will also ensure access to the highest quality clinical research and new drugs available for the treatment of sarcomas.Learn about the role of the medical oncologist in sarcoma treatment
The treatment team at Dana-Farber's sarcoma treatment center consists of more than just physicians. During your treatment, you may also meet and work with many of our vital support team members, including:
Our team can also help you find other support services within Dana-Farber, including nutrition, complementary therapies, spiritual support, financial help, survivorship and resources for families and young adults.
Because patients with sarcoma often require a combination of treatment methods, we approach the care of each patient as a team.
James Butrynski, MDGeorge D. Demetri, MDSuzanne George, MDJeffrey Morgan, MDAndrew Wagner, MD, PhD
Melissa Hohos, RNMargaret Loucks, NPMark Morley, RNKathy Polson, NPJulie Shelly, RN
Monica Bertagnolli, MDChandrajit Raut, MDJiping Wang, MDMichelle Lapidus, PA
John Ready, MDMarco Ferrone, MDAndrea Milligan, PASusanna Santos, PA
Elizabeth Baldini, MDPhillip M. Devlin, MD, FACRKaren Marcus, MD
Holcombe Grier, MDCarlos Rodriguez-Galindo, MDKatherine A. Janeway, MD
Dennis Orgill, MDJulian Pribaz, MDBohdan Pomahac, MDLifei Guo, MD, PhD
Christopher D.M. Fletcher, MDJason L. Hornick, MD, PhDJonathan A. Fletcher, MD
Annick van den Abbeele, MD
Rachel Allende, LICSW (Spanish and Portuguese-speaking patients)Larissa Hewitt, LICSWKatelyn Uyehara, LCSW (Inpatient)
We also work in close collaboration with our colleagues in the Head and Neck Oncology Program and the Thoracic Oncology Program.
The Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute — one of the largest and most respected sarcoma programs in the world — is leading critical efforts toward understanding the specific genetic changes that cause sarcomas. New findings inform the design of innovative diagnostic techniques and treatments. Our recent investigations — of unprecedented depth and scope — aim to increase treatment efficacy through research into resistance mechanisms and novel therapeutics.
Current clinical trials, listed by disease, include:
Read about our research for angiosarcomas.
Read about our research for Ewing's sarcoma.
Read about our research for GIST.
Read about our research for leiomyosarcoma and deconstructing heterogeneity in leiomyosarcoma.
Read about our research for liposarcoma.
Read about our research for osteosarcoma.
Read our research for TGCT.
Read about Dana-Farber's Sarcoma Clinical Trials.
If you have never been seen before at Dana-Farber/Brigham and Women's Cancer Center, please call 877-442-3324 or use this online form to make an appointment. For all other inquiries, please call 617-632-5204.Pediatric patients should call Dana-Farber/Children's Hospital Cancer Center at 888-PEDI ONC (733-4662).
If you are already a patient in the Center for Sarcoma and Bone Oncology, please call 617-632-5204.
If you would like to refer a patient, please call 617-632-5204, and select option 1. You can also send a fax to 617-632-3408.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: